Ovax

Ovax is an American biopharmaceutical company that specialises in developing innovative solutions to combat the opioid crisis. Using an advanced scientific approach, Ovax is developing a revolutionary vaccine to prevent fentanyl overdoses by blocking its effects before they reach the brain. This unique technology offers preventive protection and complements existing treatments such as naloxone. With over $10 million in funding and clinical trials in the pipeline, Ovax aims to transform addiction care and provide a lasting solution to the public health challenges associated with opioids.